AMYPAD is a collaborative research initiative aiming to improve the understanding, diagnosis and management of Alzheimer’s disease through the utilisation of ß-amyloid PET imaging.

This page includes papers acknowledging the AMYPAD project (i.e.  primary publications solely emanating from the AMYPAD Project, publications which rely or use AMYPAD data and affiliated papers).

This project has received funding from the Innovative Medicines Initiative 2 Joint undertaking under grant agreement No 115952. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. 

Any information on this page solely reflects the author’s view and neither IMI nor the European Union, and EFPIA are responsible for any use that may be made of the information contained herein.